Replies to post #154310 on Biotech Values

[glass_half_full]

Well, that would give ARIA 100 patient-years in the US and 150 ex-US, so right on target given zero up-take by anyone outside the comp care program.

I suppose that's a pona revenue target that's so sandbagged, it's tough not to knock it out of the park....